Back to 
CANTOR FITZGERALD, L. P.
CANTOR FITZGERALD, L. P.
AMLX
3 quarters
Position history for CANTOR FITZGERALD, L. P.'s holdings in AMYLYX PHARMACEUTICALS INC
No. Cantor Fitzgerald exited its AMLX (Amylyx Pharmaceuticals) position in Q3 2025. Its Q2 2025 13F listed 50,000 shares worth $320,500. Cantor Fitzgerald first reported AMLX in Q1 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$354,000
Total Shares Change
-100,000
Quarter-by-Quarter History